BioMarin's $4.8 Billion Amicus Acquisition Reshapes the Rare Disease Market
BioMarin Pharmaceutical will acquire Amicus Therapeutics for $4.8 billion in cash, creating a dominant force in lysosomal storage disorders.
TRENDING TOPICS
3286 articles found for "investing"
BioMarin Pharmaceutical will acquire Amicus Therapeutics for $4.8 billion in cash, creating a dominant force in lysosomal storage disorders.
Insilico Medicine raised HKD 2.277 billion in Hong Kong's largest biotech IPO of 2025, marking a milestone for AI-powered pharmaceutical development.
Starting January 1, 2026, China's new silver export restrictions will block smaller exporters and create a global supply shock. Here's what investors need to know.
Applied Digital announced plans to spin off its cloud business and merge it with Ekso Bionics to create ChronoScale, a new AI-focused computing platform.
Google's Gemini AI has tripled its market share from 5% to 18% in 2025, sending OpenAI into 'code red' mode as Alphabet emerges as the new AI leader.
Meta Platforms acquires Singapore-based AI startup Manus for up to $3 billion, marking its largest AI deal of 2025 and signaling a major push into autonomous AI agents.
U.S. bonds delivered their best returns since 2020 in 2025, but strategists warn that 2026 may bring tougher sledding as Fed rate cuts slow and inflation remains stubborn.
U.S. IPO volume surged 56% in 2025 as 344 companies raised nearly $53 billion. From Medline's $6.3B offering to Circle's 168% first-day pop, here's how the IPO market roared back to life.
Crude prices jumped over 2% Monday after Iran's president declared his country is in 'full-scale war' with the U.S., Europe, and Israel, as Trump and Netanyahu met to discuss Middle East strategy.
Nvidia shares have retreated 8% from October highs after becoming the first company to hit $5 trillion. Analysts debate whether this is a buying opportunity or a warning sign.
Gold plunged 5% and silver crashed 11% on December 29 in their biggest intraday drops in years, as profit-taking and dollar strength triggered a precious metals selloff.
The S&P 500 fell 0.35% and the Nasdaq dropped 0.5% on Monday as Nvidia, Tesla, and other tech leaders retreated, casting doubt on whether the traditional year-end rally can materialize.